Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION USP
| Report ID | 8417 |
| Drug Identification Number | 02347830 |
| Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION USP |
| Common or Proper name | ROPIVACAINE |
| Company Name | PFIZER CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | BLOCK/INFILTRATION EPIDURAL |
| Packaging size | 10x10mL |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-05-09 |
| Estimated end date | |
| Actual end date | 2018-10-01 |
| Shortage status | Resolved |
| Updated date | 2018-10-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.